ASB2 and acute promyelocytic leukemia: ASB2 is not only activated upon retinoic acid-differentiation of PML-RARα-expressing APL cells but also upon granulocytic maturation of non-APL acute myeloid leukemia treated with retinoic acid in combination with the inhibitor of lysine-specific demethylase 1 tranylcypromine [11].